The role of Adenosine Deaminase 2 (ADA2) has moved far beyond simply metabolizing adenosine. Recent breakthroughs have identified ADA2 as a critical lysosomal protein that edits DNA, directly impacting how our innate immune system senses pathogens .
For researchers studying DADA2 (Deficiency of ADA2) —a severe autoinflammatory condition mimicking vasculitis—or the tumor microenvironment, understanding the monocyte lineage is key. However, obtaining patient-derived primary cells is difficult.
This is where the AhelixBio ADA2 Knockout (KO) THP-1 Cell Line becomes indispensable. By leveraging the power of the THP-1 human monocytic model, we provide a clean, stable genetic background to dissect the mechanisms of ADA2 deficiency.
THP-1 cells are the gold standard for studying monocyte and macrophage biology. They are easier to transfect and culture than primary human monocytes.
1. Validating the Lysosomal DNA Editing Hypothesis
Recent evidence suggests ADA2 is not primarily an extracellular enzyme. Research indicates it localizes to lysosomes where it converts deoxyadenosine (dA) to deoxyinosine (dI) in DNA . In our ADA2 KO THP-1 model, this editing function is absent. This allows researchers to ask:
How does the accumulation of dA-rich DNA in lysosomes affect Toll-like receptor 9 (TLR9) activation?
Does the loss of ADA2 turn "self" DNA into an inflammatory trigger?
2. Macrophage Polarization (M1 vs. M2)
ADA2 activity is strongly linked to macrophage phenotype. Studies show that ADA2 correlates with the M2 (anti-inflammatory/tumor-promoting) phenotype . Conversely, DADA2 patients (ADA2 deficient) skew towards an M1 (pro-inflammatory) state, driving TNF-alpha production .
The AhelixBio Advantage: Differentiate our KO cells into macrophages and observe the spontaneous shift toward M1 markers. Validate this by measuring cytokines like IL-6 and TNF-alpha via ELISA.
3. Modeling DADA2 in a Dish
While rodents lack a perfect ADA2 ortholog, human THP-1 cells replicate the human condition. Using our CRISPR/Cas9 generated KO line, scientists can recapitulate the inflammatory phenotype seen in patients without the variability of patient blood draws.
Why choose AhelixBio for your immunology toolbox?
Guaranteed Knockout: Verified by Western blot and genomic sequencing to ensure complete absence of ADA2 protein.
Functional Validation: We don't just sequence; we validate. Our QC includes confirming the hyper-inflammatory response to TLR agonists compared to Wild Type.
Ready to Use: Save 3-4 months of cloning time. Arrives cryopreserved or in culture, ready for your differentiation protocol (PMA to Macrophages).
Autoinflammatory Disease Modeling: Study the pathogenesis of vasculitis and stroke in DADA2.
Immuno-Oncology: Investigate how ADA2 in tumor-associated macrophages (TAMs) suppresses the immune response, allowing tumors to grow .
Innate Immunity: Map the crosstalk between ADA2, the adenosine receptor A2bR, and hematopoietic stem cell emergence .
The biology of ADA2 is complex—bridging the gap between metabolism, DNA sensing, and inflammation. The AhelixBio ADA2 Knockout THP-1 Cell Line offers a precise, reproducible model to untangle these pathways.
Whether you are screening for drugs to treat DADA2 or looking to re-educate macrophages in cancer, this cell line is your shortcut to high-impact data.
Order the AhelixBio ADA2 KO THP-1 Cell Line today and accelerate your inflammation research.
